Psychedelics Company MindMed Prices Public Offering Aiming To Raise $75M
A psychedelics-focused biopharmaceutical company Mind Medicine (MindMed) (NASDAQ:MNMD) announced Friday the pricing of an underwritten public offering of 9.29 million shares without par value, at a price of $7.00 per share. Through this round, the New York-headquartered company aims to raise $75 million.
MindMed also announced offering pre-funded warrants to certain investors, allowing them to buy 1.43 million shares at a price of $6.999 per pre-funded warrant.
The company intends to use the proceeds from the offering to support the research and development of its product candidates, working capital and general corporate purposes.
Leerink Partners and Evercore ISI are acting as …